Armuzzi A - Search Results

1

Ileal Crohn disease: mural microvascularity quantified with contrast-enhanced US correlates with disease activity.

De Franco A, Di Veronica A, Armuzzi A, Roberto I, Marzo M, De Pascalis B, De Vitis I, Papa A, Bock E, Danza FM, Bonomo L, Guidi L. De Franco A, et al. Among authors: armuzzi a. Radiology. 2012 Feb;262(2):680-8. doi: 10.1148/radiol.11110440. Epub 2011 Dec 12. Radiology. 2012. PMID: 22157203

2

Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice?

Candelli M, Papa A, Nista EC, Danese S, Armuzzi A, Bartolozzi F, Tondi P, Ojetti V, Gasbarrini G, Gasbarrini A. Candelli M, et al. Among authors: armuzzi a. Hepatogastroenterology. 2003 May-Jun;50(51):718-20. Hepatogastroenterology. 2003. PMID: 12828069

3

Sacroileitis and peripheral arthropathy associated with ulcerative colitis: effect of infliximab on both articular and intestinal symptoms.

Lupascu A, Armuzzi A, De Pascalis B, Carloni E, Lauritano EC, Gasbarrini A, Pola P, Gasbarrini A. Lupascu A, et al. Among authors: armuzzi a. Dig Liver Dis. 2004 Jun;36(6):423-5. doi: 10.1016/j.dld.2003.10.021. Dig Liver Dis. 2004. PMID: 15248384

4

Prevalence of the K469E polymorphism of intercellular adhesion molecule 1 gene in Italian patients with inflammatory bowel disease.

Papa A, Pola R, Flex A, Danese S, Armuzzi A, Gaetani E, Guidi L, De Vitis I, Urgesi R, Grillo A, Serricchio M, Proia AS, Fedeli G, Gasbarrini G, Pola P, Gasbarrini A. Papa A, et al. Among authors: armuzzi a. Dig Liver Dis. 2004 Aug;36(8):528-32. doi: 10.1016/j.dld.2004.03.015. Dig Liver Dis. 2004. PMID: 15334773

5

Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation.

Danese S, Semeraro S, Marini M, Roberto I, Armuzzi A, Papa A, Gasbarrini A. Danese S, et al. Among authors: armuzzi a. Dig Liver Dis. 2005 Nov;37(11):811-8. doi: 10.1016/j.dld.2005.03.013. Epub 2005 Sep 13. Dig Liver Dis. 2005. PMID: 16168725 Review.

6

A novel pathogenic role for microvasculature in inflammatory bowel disease.

Danese S, Papa A, Scaldaferri F, Graziani C, Bonizzi M, Armuzzi A, Fedeli G, Gasbarrini G, Gasbarrini A. Danese S, et al. Among authors: armuzzi a. Eur Rev Med Pharmacol Sci. 2006 Jan-Feb;10(1):3-5. Eur Rev Med Pharmacol Sci. 2006. PMID: 16494103

7

Growth hormone in inflammatory bowel disease.

De Pascalis B, Bianchi A, Satta MA, Lupascu A, Mentella MC, Leo D, Fiore F, Fedeli P, Pontecorvi A, Pola P, Melina D, Gasbarrini A, De Marinis L, Armuzzi A. De Pascalis B, et al. Among authors: armuzzi a. Eur Rev Med Pharmacol Sci. 2006 Jan-Feb;10(1):13-6. Eur Rev Med Pharmacol Sci. 2006. PMID: 16494105 Review.

8

Contrast-enhanced ultrasonography with SonoVue after infliximab therapy in Crohn's disease.

Guidi L, De Franco A, De Vitis I, Armuzzi A, Semeraro S, Roberto I, Papa A, Bock E, Gasbarrini G, Fedeli G. Guidi L, et al. Among authors: armuzzi a. Eur Rev Med Pharmacol Sci. 2006 Jan-Feb;10(1):23-6. Eur Rev Med Pharmacol Sci. 2006. PMID: 16494107 Clinical Trial.

9

Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease.

Schinzari F, Armuzzi A, De Pascalis B, Mores N, Tesauro M, Melina D, Cardillo C. Schinzari F, et al. Among authors: armuzzi a. Clin Pharmacol Ther. 2008 Jan;83(1):70-6. doi: 10.1038/sj.clpt.6100229. Epub 2007 May 16. Clin Pharmacol Ther. 2008. PMID: 17507924 Clinical Trial.

10

Infliximab in Crohn's disease: early and long-term treatment.

Armuzzi A, De Pascalis B, Fedeli P, De Vincentis F, Gasbarrini A. Armuzzi A, et al. Dig Liver Dis. 2008 Jul;40 Suppl 2:S271-9. doi: 10.1016/S1590-8658(08)60537-X. Dig Liver Dis. 2008. PMID: 18599000

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

414 results

Search Page

Filters